Health care economics articles within Nature Communications

Featured

  • Article
    | Open Access

    Use of cloud-based personal health records are increasing globally. Here, authors introduce the Global Patient co-Owned Cloud (GPOC) concept. The systematic review and meta-analysis examine factors like data security, efficiency, privacy, and cost. It aims to establish a scientific basis for a GPOC, which may disseminate global artificial intelligence for healthcare.

    • Niklas Lidströmer
    • , Joe Davids
    •  & Eric Herlenius

  • Article
    | Open Access

    Control of rabies in Africa through mass vaccination of dogs may be compromised by cross-border transmission. Here, the authors use mathematical modelling and a benefit-cost analysis to demonstrate that coordinating rabies control measures across borders could lead to the elimination of dog rabies in Africa.

    • A. Bucher
    • , A. Dimov
    •  & J. Zinsstag

  • Article
    | Open Access

    Health care workers were at high risk of SARS-CoV-2 infection in the early stage of the pandemic, and this had knock-on effects including secondary infections and disruptions in health service delivery. Here, the authors estimate the economic impacts of SARS-CoV-2 infections in health care workers at the society level in five low- and middle-income country settings.

    • Huihui Wang
    • , Wu Zeng
    •  & Mickey Chopra

  • Comment
    | Open Access

    Economic evaluations of public health interventions to prevent malaria should consider the adoption of wider perspectives and the inclusion of non-health impacts, particularly economic development outcomes, such as education. This is especially relevant in malaria elimination settings and in the context of the current SARS-CoV-2 pandemic.

    • Elisa Sicuri
    • , Francesco Ramponi
    •  & Francisco Saúte

  • Article
    | Open Access

    Cost, supply and logistics present challenges to COVID-19 vaccine rollout in low and middle income countries. Here, the authors model vaccination programmes in South Africa and demonstrate the importance of the pace of vaccine rollout, with even moderately efficacious vaccines likely to be cost-effective.

    • Krishna P. Reddy
    • , Kieran P. Fitzmaurice
    •  & Mark J. Siedner

  • Article
    | Open Access

    Dexamethasone has been shown to have survival benefits for critically ill patients hospitalised with COVID-19 in the UK. Here, the authors estimated the number of lives that could be saved through a UK and global roll out of the drug and demonstrate that it is a cost-effective option.

    • Ricardo Águas
    • , Adam Mahdi
    •  & Mesulame Namedre

  • Article
    | Open Access

    Foreign aid is necessary to control tropical diseases in endemic countries. Here the authors outline the steps taken to control malaria in Africa since 2000 and present an economic model to propose that US$25−30 per capita will be needed to avoid a disease trap.

    • Eric Maskin
    • , Célestin Monga
    •  & Jean-Claude Berthélemy

  • Article
    | Open Access

    Several drug combinations with different properties are used for malaria treatment. Here, Okell et al. use a mathematical model to simulate malaria transmission and treatment with two drug combinations in Africa, and find that locally optimized policies can be highly cost effective for reducing malaria burden.

    • Lucy C. Okell
    • , Matthew Cairns
    •  & Azra C. Ghani

Browse broader subjects

Browse Health care economics across other nature.com journals